Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05709873 · ClinicalTrials.gov registry record · NA
Narcolepsy Nightmare Study
A NA study of Narcolepsy and Narcolepsy Type 1, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05709873 is a NA study of Narcolepsy and Narcolepsy Type 1 that has completed, run by Northwestern University. The registered enrollment target is 7 participants, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05709873, a NA study of Narcolepsy and Narcolepsy Type 1, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) to IRT make it more effective? Participants will be randomized to one of two treatment groups and will be asked to: * Complete a daily log of sleep symptoms for up to 13 weeks. * Attend 7 sessions of treatment. * Complete questionnaires before and after treatment. * Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).
Conditions Studied
Interventions
- BEHAVIORAL Imagery rehearsal therapy
- BEHAVIORAL Targeted dream control
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05709873
The ClinicalTrials.gov registry entry for NCT05709873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Narcolepsy appearing as the primary indexed condition, and to 2 interventions - of which Imagery rehearsal therapy is the first listed.
NCT05709873 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05709873 about?
NCT05709873 is a clinical study titled "Narcolepsy Nightmare Study". The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) to IRT make it more e...
What is the current status of trial NCT05709873?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-22. Estimated completion is 2024-04-30.
What conditions does trial NCT05709873 study?
This clinical trial studies the following conditions: Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 2, Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy.
What interventions are being tested in trial NCT05709873?
The interventions under investigation include: Imagery rehearsal therapy (BEHAVIORAL), Targeted dream control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05709873?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05709873 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Narcolepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psychosocial Adjunctive Treatment for Hypersomnia (PATH)
COMPLETED · NA
-
SUNOSI® (Solriamfetol) Pregnancy Registry
RECRUITING
-
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
RECRUITING · Phase 1
-
Child and Adolescent Registry for Participants With Narcolepsy
RECRUITING
-
WAKIX® (Pitolisant) Pregnancy Registry
RECRUITING
-
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.